The daily treatment of type 1 diabetes is a continuous and sophisticated process of balancing insulin administration with nutritional intake and physical activity. Because the body can no longer produce insulin due to an autoimmune response, individuals must perform the role of a surrogate pancreas to maintain blood glucose levels within a safe range. In the United Kingdom, this management has been transformed by a shift toward person centred care and the rapid integration of automated medical technology. While the biological requirement for insulin remains lifelong, the modern daily routine prioritizes flexibility and precision, allowing patients to lead active lives while minimizing the risk of complications.
What We’ll Discuss in This Article
- The structure of basal bolus insulin regimens and injection techniques.
- The role of insulin pumps and advanced hybrid closed loop systems.
- Methods for blood glucose monitoring using CGM and finger prick tests.
- The importance of carbohydrate counting and nutritional flexibility.
- Managing physical activity and preventing hypoglycemia (hypos).
- Utilizing sick day rules and attending regular clinical reviews.
Daily Insulin Therapy and Regimens
The primary treatment for type 1 diabetes is the daily administration of insulin to regulate blood sugar levels. Because insulin is a protein that would be destroyed by stomach acids if taken orally, it must be delivered into the fatty layer beneath the skin. In 2026, most individuals in the UK follow a basal bolus regimen, which uses two distinct types of insulin to mimic natural pancreatic function. Basal (or background) insulin is a long acting dose taken once or twice a day to maintain stable glucose levels during fasting periods, such as between meals and overnight.
The second part of the regimen is bolus (or mealtime) insulin, which is a rapid acting dose taken before eating or drinking anything containing carbohydrates. This insulin is designed to work quickly to manage the glucose spike that follows a meal. Modern ultra rapid analogues can be taken within minutes of eating, providing greater flexibility. In 2026, many patients utilize smart insulin pens that record the time and size of each dose, sending data to a smartphone app to help track daily injections. Proper technique involves rotating injection sites—typically the abdomen, thighs, or buttocks—to prevent the buildup of fatty lumps known as lipohypertrophy, which can interfere with insulin absorption.
Automated Insulin Delivery: Hybrid Closed Loop Systems
A significant advancement in daily treatment is the rollout of hybrid closed loop (HCL) technology, often referred to as an artificial pancreas. This system consists of an insulin pump and a continuous glucose monitor (CGM) that communicate via a complex algorithm. The pump delivers a continuous flow of rapid acting insulin, replacing the need for long acting background injections. The CGM measures glucose levels every few minutes and the algorithm automatically adjusts the pump’s insulin delivery to respond to rising or falling sugar levels.
According to the latest NICE guidance, hybrid closed loop systems are being phased in across the NHS over a five year period for eligible groups. In early 2026, priority is given to children and young people, pregnant individuals, and adults with disabling hypoglycemia or high HbA1c levels despite optimized management. While these systems automate many decisions, they remain “hybrid” because users must still manually input their carbohydrate intake at mealtimes. By providing a “safety net” that can suspend insulin if a hypo is predicted, these systems significantly reduce the daily mental burden of diabetes management.
Blood Glucose Monitoring and Targets
Regular monitoring of blood glucose is essential for making safe treatment decisions throughout the day. In the UK, it is recommended that individuals check their levels at least four to five times daily, including before meals and at bedtime. Most patients now use a Continuous Glucose Monitor (CGM) or Flash Glucose Monitor, which uses a sensor on the arm or abdomen to provide real time readings and trend arrows. These arrows indicate if blood sugar is stable, rising, or falling, allowing for proactive adjustments to insulin or food intake.
Clinical targets for 2026 follow established NICE NG17 guidelines, though individual targets are agreed with a specialist care team. As a general guide, adults aim for a fasting plasma glucose level of 5 to 7 mmol/L upon waking and 4 to 7 mmol/L before meals. Post meal targets, taken at least 90 minutes after eating, are generally 5 to 9 mmol/L. For those using technology, a target of spending at least 70 percent of the day within a range of 3.9 to 10.0 mmol/L is often used as a benchmark for successful daily control.
Carbohydrate Counting and Nutrition
Daily management relies heavily on carbohydrate counting (carb counting), which allows individuals to match their bolus insulin dose to the amount of sugar they consume. Carbohydrates are found in many foods, including grains, starchy vegetables, fruit, and dairy. By calculating the total grams of carbs in a meal, a person can apply their personalized insulin to carb ratio to determine the exact dose required. This skill is typically taught through structured education programmes like DAFNE (Dose Adjustment for Normal Eating).
A healthy, balanced diet is recommended for everyone with type 1 diabetes to support long term cardiovascular health. There is no such thing as a “diabetic diet,” but choosing low glycaemic index (GI) foods that release sugar more slowly can make blood sugar levels more predictable. In 2026, nutritional advice focuses on flexibility; once a person masters carb counting, they can integrate a wide variety of foods into their daily life. If blood sugar is high before a meal, a “correction dose” may be added to the mealtime bolus to bring the level back toward the target range.
Managing Activity and Preventing Hypos
Physical activity is highly beneficial but introduces complexity to daily management, as exercise increases insulin sensitivity and uses up glucose as fuel. This can lead to hypoglycemia (a “hypo”), which is when blood sugar drops below 4.0 mmol/L. Daily care includes checking blood glucose before, during, and after exercise. Depending on the intensity and duration of the activity, an individual may need to reduce their insulin dose or consume extra carbohydrates to prevent a drop.
Treating a hypo requires immediate action with 15 grams of fast acting sugar, such as glucose tablets, five jelly babies, or 150ml of a sugary drink. This is followed by a retest after 15 minutes. If the level has risen above 4.0 mmol/L, a longer acting carbohydrate snack is eaten to stabilize the blood sugar. Adults with type 1 diabetes must also be aware of daily factors that can cause hypos, such as drinking alcohol on an empty stomach or miscalculating a mealtime bolus. Carrying medical identification and always having hypo treatment available are essential daily safety requirements.
Illness Management and Clinical Reviews
When a person with type 1 diabetes becomes ill, their blood sugar levels often rise as the body releases stress hormones to fight the infection. Daily treatment during illness follows “sick day rules,” which include checking blood glucose more frequently (often every two to four hours) and checking for ketones in the blood or urine. Ketones are acidic byproducts produced when the body breaks down fat for energy instead of glucose, which can lead to a dangerous condition called diabetic ketoacidosis (DKA). Even if the person is not eating, they usually still require insulin during illness to manage these elevated levels.
In addition to daily self care, individuals attend regular clinical reviews every three to six months. These reviews include an HbA1c test, which measures average blood sugar levels over the previous eight to twelve weeks. In 2026, an HbA1c target of 48 to 53 mmol/mol is often recommended to reduce the risk of future eye and kidney disease. Annual check ups also include foot examinations and diabetic eye screening to detect early signs of retinopathy. Engaging with a multidisciplinary care team including specialist nurses, dietitians, and consultants is vital for refining the daily treatment plan as the person’s needs evolve.
Conclusion
The daily treatment of type 1 diabetes in 2026 involves a combination of insulin therapy, precise carbohydrate counting, and the use of advanced monitoring technology. Whether using multiple daily injections or a hybrid closed loop system, the primary objective is to maintain blood glucose levels within a safe target range. Success relies on consistent self monitoring, the ability to recognize and treat hypoglycemia, and the application of sick day rules during illness. Regular engagement with a specialist diabetes team ensures that the daily routine remains effective and utilizes the latest clinical advancements. If you experience severe, sudden, or worsening symptoms, call 999 immediately.
Can I miss a daily insulin dose if I am not eating?
No, you must never stop taking your background (basal) insulin, as your body needs it for basic functions even when you are not eating; consult your care team for guidance during fasting.
Is it better to use an insulin pen or an insulin pump?
Both are effective; an insulin pen is simple and portable, while a pump provides a continuous flow that can offer more flexibility and better control for some people.
Why do I need to rotate my injection sites every day?
Rotating sites prevents the buildup of hard, fatty lumps that can make your insulin work less effectively and lead to unpredictable blood sugar levels.
Can I still play sports with type 1 diabetes?
Yes, exercise is encouraged, but you will need to plan ahead by checking your glucose levels and adjusting your insulin or carbohydrate intake as discussed with your team.
How often should I replace my CGM sensor?
Most continuous glucose monitor sensors last between 10 and 14 days, though you should follow the specific manufacturer’s instructions for the device you are using.
What should I do if my blood ketones are high?
If your ketones are above 1.5 mmol/L, follow your sick day rules and contact your diabetes team or NHS 111 immediately, as this can indicate a serious condition.
Do I need to do finger-prick tests if I have a CGM?
While a CGM reduces the need, you still need to do finger prick tests if your symptoms do not match the sensor reading or if your device requires calibration.
Authority Snapshot
This guide to the daily treatment of type 1 diabetes in 2026 provides evidence-based information to help patients manage their lifelong metabolic health. It has been written by Dr. Rebecca Fernandez, a UK trained physician with an MBBS and experience in internal medicine, cardiology, and emergency care. Dr. Fernandez has managed thousands of patients with chronic metabolic conditions and provides care that aligns strictly with the latest 2026 NHS and NICE guidance to ensure medical accuracy and patient safety.
